Collaboration accelerates insights on clinical benefits of molecular profiling across all major categories of disease SAN DIEGO and CHICAGO, April…
The Arkansas-based not-for-profit now uses DeepScribe's oncology-specific AI to document and deliver insights for patients SAN FRANCISCO, April 15, 2025 /PRNewswire/…
WASHINGTON, April 15, 2025 /PRNewswire/ -- June 4-7, 2025 – Keystone Symposia will host a timely meeting, "Vaccinology: Horizons Across Disease,…
Rapidly growing lung health company aims to redefine early diagnosis and precision lung cancer care using multi-modal artificial intelligence (AI).…
Virtual KOL Event on Wednesday, April 23, 2025, at 2:30 p.m. ET CAMBRIDGE, Mass., April 15, 2025 /PRNewswire/ -- Leap Therapeutics,…
Dr. Chung brings expertise in scaling medical teams to Ezra’s mission of making early cancer detection accessible to everyone Dr.…
RMAT designation was granted based on promising clinical data from the ongoing Phase 1/2 trial of LYL314 in patients with…
Veteran Oncologist and Clinical Development expert to lead global medical strategy supporting patient-focused drug development and deliveryDURHAM, N.C., April 15,…
Created to distinguish the most remarkable scientific discoveries in the biomedical field, this international award has been granted a growing reputation…
RESTON, Va., April 14, 2025 /PRNewswire/ -- The theoretical radiation risk proposed by Smith-Bindman, et al, is consistent with prior…